Portfolio Update

4 January 2008 THE BIOTECH GROWTH TRUST PLC (the "Company") QUARTERLY STATEMENT OF INVESTMENTS The Company announces that the ten largest investments as at close of business on 31 December 2007 were as follows: * Investments valuing greater than 5% of the Company's gross assets comprise the following: Company Name Value of Investment % of Total at Portfolio Assets 31 December 2007 AMGEN COM USD0.0001 6,718,939 9.25 GILEAD SCIENCES INC COM USD0.001 6,469,004 8.90 UK TREASURY 8% 29/09/13 5,985,870 8.24 BIOGEN IDEC COM USD0.0005 5,061,208 6.97 GENZYME CORP GENERAL DIVISION COM USD0.01 4,835,595 6.66 * The ten largest investments held by the Company comprise the following: Company Name Value of Investment % of Total at Portfolio Assets 31December 2007 AMGEN COM USD0.0001 6,718,939 9.25 GILEAD SCIENCES INC COM USD0.001 6,469,004 8.90 UK TREASURY 8% 29/09/13 5,985,870 8.24 BIOGEN IDEC COM USD0.0005 5,061,208 6.97 GENZYME CORP GENERAL DIVISION COM USD0.01 4,835,595 6.66 GENENTECH INC COM STK USD0.02 NPV 3,167,176 4.36 IMCLONE SYSTEMS COM USD0.001 3,076,796 4.24 ALLOS THERAPEUTICS COM STK US$0.01 2,764,870 3.81 BIOMARIN PHARMACEUTICAL COM STK USD0.001 2,487,923 3.42 INDEVUS PHARMACEUTICALS INC USD0.001 2,333,869 3.21 - ENDS - For further information please contact: Mark Pope, Company Secretary Frostrow Capital LLP Telephone: 020 3 008 4913
UK 100

Latest directors dealings